District Municipality of Muskoka

High Tide to Acquire Bud Heaven, Adding Two Established Retail Cannabis Stores in Ontario

Retrieved on: 
Wednesday, March 30, 2022
TSX Venture Exchange, Restaurant, High Tide, Crossroads, Intention, AB, FSE, Alcohol and Gaming Commission of Ontario, SEDAR, View, Blackpool High Tide Organ, EDGAR, Town, Heart, NASDAQ, Transaction, Forward-looking statement, Store, Multimedia, Consideration, CAD, AZ Business Magazine, Tide, Cannabis, Company, Person, District Municipality of Muskoka, TSX, CBD, Bud, Projection, News, Acquisition, TSX Venture 50, Retail, Drug, Risk management, Bracebridge

The Stores are the only retail cannabis stores that are currently operational in the Town of Bracebridge.

Key Points: 
  • The Stores are the only retail cannabis stores that are currently operational in the Town of Bracebridge.
  • "With this announcement, we are continuing to consolidate the Ontario cannabis retail space at accretive multiples for our shareholders.
  • Upon the closing of Bud Heaven, as well as the Crossroads transaction announced earlier this month, High Tide will have at least 40 stores in Ontario and 119 stores nationwide.
  • High Tide to Acquire Bud Heaven, Adding Two Established Retail Cannabis Stores in Ontario
    View original content to download multimedia: https://www.prnewswire.com/news-releases/high-tide-to-acquire-bud-heaven...

Microbix Presenting at Muskoka Capital Conference

Retrieved on: 
Wednesday, September 25, 2019
JW Marriott Hotels, Muskoka Cottage Brewery, MBX, District Municipality of Muskoka

MISSISSAUGA, Ontario, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix), an innovator of clinical diagnostic materials and medical devices for test quality control, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and being held at the JW Marriott Rosseau Muskoka, in Minett, ON, September 27-29, 2019.

Key Points: 
  • MISSISSAUGA, Ontario, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix), an innovator of clinical diagnostic materials and medical devices for test quality control, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and being held at the JW Marriott Rosseau Muskoka, in Minett, ON, September 27-29, 2019.
  • Microbixs CEO, Cameron Groome, will undertake a series of 18 one-on-one meetings with growth company investors during the formal portion of the conference.
  • Microbix specializes in developing proprietary biological and technology solutions for human health and well-being, with sales now exceeding $1 million per month.
  • Microbix antigens and QAPs are sold to many customers worldwide, at present primarily to multinational diagnostics companies and laboratory accreditation organizations.